Aerovate Therapeutics, Inc. (AVTE)

NASDAQ: AVTE · Real-Time Price · USD

2.680

-0.040 (-1.47%)

At close: Apr 25, 2025, 4:00 PM

2.640

-0.040 (-1.49%)

After-hours: Apr 25, 2025, 7:18 PM EDT

Aerovate Therapeutics Employees

Aerovate Therapeutics had 30 employees as of December 31, 2024. The number of employees decreased by 21 or -41.18% compared to the previous year.

Employees

30

Change (1Y)

-21

Growth (1Y)

-41.18%

Revenue / Employee

n/a

Profits / Employee

-$1,632,000

Market Cap

77.68M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	30	-21	-41.18%
Dec 31, 2023	51	8	18.60%
Dec 31, 2022	43	27	168.75%
Dec 31, 2021	16	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

AVTE News

6 days ago - Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals - PRNewsWire
18 days ago - Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PRNewsWire
20 days ago - Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PRNewsWire
5 weeks ago - AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE - Business Wire
6 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - PRNewsWire
10 months ago - Aerovate Therapeutics to Explore Strategic Alternatives - GlobeNewsWire
11 months ago - Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC - GlobeNewsWire
11 months ago - Aerovate Therapeutics Investors: Investigation on behalf of investors; the Portnoy Law Firm - GlobeNewsWire